1 Followers
25 Following
rushi2121

rushi2121

Deep Brain Stimulation Devices Market is Thriving According to New Report: Opportunities Rise For Stakeholders by 2026

Deep brain stimulation (DBS) surgery is performed as part of the treatment of various neural debilitating conditions such as Parkinson’s disease (PD), dementia, and Alzheimer’s disease.

Deep Brain Stimulation Devices Market is Thriving According to New Report: Opportunities Rise For Stakeholders by 2026

Deep brain stimulation (DBS) surgery is performed as part of the treatment of various neural debilitating conditions such as Parkinson’s disease (PD), dementia, and Alzheimer’s disease. A patient fitted with a DBS device can get long-term relief from debilitating symptoms of PD. Although some patients may require medications post-surgery, there is significant reduction in side-effects caused due to medications, owing to use of DBS devices. A DBS device is mainly placed in one of the three U.S. Food and Drug Administration (FDA) approved target sites in PD. Most commonly preferred target sites are the Globus Pallidus Interna (GPi) and Subthalamic Nucleus (STN).

 

Get Exclusive Sample Report at: https://www.coherentmarketinsights.com/insight/request-sample/84

 

Market Dynamics

 

Approval and launch of novel and advanced DBS devices is expected to drive the global deep brain stimulation devices market growth over the forecast period. For instance, in 2017, Boston Scientific Corporation received the U.S. Food and Drug Administration for its Vercise Deep Brain Stimulation (DBS) system. Vercise DBS system is indicated for use in Parkinson’s disease treatment. DBS works by stimulating a targeted region of the brain through implanted leads that are powered by a device called an implantable pulse generator (IPG).

 

Frequent approval and Launch of novel devices is expected to fuel the global deep brain stimulation devices market growth

 

Key players in the market are focused on approval and launch of novel DBS devices to expand their product portfolio, which is expected to boost the market growth. For instance, in January 2019, Boston Scientific Corporation launched two new DBS devices namely the Vercise Primary Cell (PC) and Vercise Gevia Deep Brain Stimulation (DBS) systems.

 

In June 2015, the U.S. Food and Drug Administration (FDA) approved St. Jude Medical’s Brio Neurostimulation System, a DBS device that helps to reduce symptoms of Parkinson’s disease (PD) and essential tremor. Launch and approval of such novel devices is expected to significantly support the global deep brain stimulation devices market growth over the forecast period.

 

 

The global deep brain stimulation devices market size was valued at US$ 831.6 Mn in 2018, and is expected to exhibit a CAGR of 9.7% over the forecast period (2020 – 2027).

 

Detailed Segmentation:

 

Global Deep Brain Stimulation Devices Market, By Application:

Parkinson's Disease

Essential Tremor

Dystonia

Others

 

Global Deep Brain Stimulation Devices Market, By End User:

Hospital & Clinics

Ambulatory Surgical Centers

Others

 

Global Deep Brain Stimulation Devices Market, By Region:

North America

Europe

Asia Pacific

Latin America

Middle East

Africa

 

Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/84

 

High prevalence of diseases such as Parkinson’s disease and epilepsy is expected to fuel the global deep brain stimulation devices market growth

 

Increasing prevalence of PD is expected to boost demand for DBS devices. For instance, according to the Parkinson’s Disease Foundation, as of 2016, over 10 million people are suffering from Parkinson’s disease, worldwide. The findings published by the organization demonstrated that incidence rate of PD increases with age and only 4% of people were diagnosed with PD before the age of 50 years. According to the same source, in 2017, the incidence rate of PD in the U.S is as high as 60,000, annually.

 

Moreover, according to Parkinson’s Australia Inc. around 11,544 new cases of PD were diagnosed in Australia in 2014. According to the statistics released by Parkinson Canada, the number of people suffering from PD in Canada is expected to reach over 163,700 by 2031 (double than the prevalence in 2011).

 

Key players operating in the global deep brain stimulation devices market include, Boston Scientific Corporation, Medtronic, Inc., St. Jude Medical, Inc. (Abbott Laboratories), Cyberonics, Inc., Neuronetics, and Aleva Neurotherapeutics SA.

 

About Coherent Market Insights

 

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

 

 

Contact Us

 

Mr. Shah

Coherent Market Insights

1001 4th Ave, #3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Product Details and Scope of Medical Cannabis Market in US - Latest Research Till 2026

Medicinal cannabis, also known as medical marijuana, is used either for the treatment of diseases or to improve their symptoms.

Product Details and Scope of Medical Cannabis Market in US - Latest Research Till 2026

Medicinal cannabis, also known as medical marijuana, is used either for the treatment of diseases or to improve their symptoms. The two cannabinoids - delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) are used in treatment of certain diseases or health conditions such as pain, blood pressure, memory, concentration, appetite, sensory stimulus, muscular problems, and seizures. Marijuana was the most widely used drug globally in 2014 with around 183 million users. Such factors have led to increasing initiatives among governments worldwide to conduct studies regarding legalization of the drug for medicinal use. The U.S National Institute on Drug Abuse is conducting research on cannabis (marijuana) to treat numerous diseases and conditions such as autoimmune diseases, pain, inflammation, seizures, mental disorders, and substance abuse disorders. Regulatory compliance is a key factor that influences cost, quality, and safety of cannabis (marijuana) as well as the capacity for the manufacturers in the medicinal cannabis market to be responsive, scalable, and innovative.

 

Get Exclusive Sample Report at: https://www.coherentmarketinsights.com/insight/request-sample/40

 

Market Dynamics

 

According to the Medical Marijuana, Inc., the legal marijuana industry in the U.S. was valued at US$ 7.1 billion in 2016, with an increase of 25% Y-o-Y. In 2016, 28 states in the U.S. legalized marijuana for medicinal purposes. In November 2016, California, Nevada, Maine, and Massachusetts legalized recreational use of marijuana. Increasing legalization of cannabis (marijuana) in the U.S. has attracted attention of global investors in the medicinal cannabis market.

 

Increasing technological advancements in testing cannabis quality made easier for manufacturer to develop the new cannabis medicines to various disease indications, which is expected to drive growth of medicinal cannabis market. For instance, in November 2018, PerkinElmer, Inc. launched its QSight 400 Series Triple Quad Mass Spectrometer, which is a highly sensitive analytical instrument designed for rapid identification and quantitation of pesticides, mycotoxins, contaminants in complex food, cannabis, and environmental testing applications.

 

Similarly, in November 2016, Waters Corporation expanded its CORTECS Columns product line, with the launch of two novel chemistries— CORTECS T3 and CORTECS Shield RP18. These new CORTECS column chemistries have enabled scientists to obtain additional information per analysis and reduce cost of analyzing complex samples including synthetic cannabinoids, biomarkers, natural products, counterfeit cosmetics, veterinary drugs, drinking water, and vitamins.

 

Furthermore, in Middle East, Israel has approved the medical cannabis products. In Africa, Lesotho and Malawi (South Africa) governments have granted a license for medicinal marijuana in 2017. In June 2017, Verve Dynamics, a Cape Town, South Africa-based alternative medicines company received a license from the government of Lesotho to cultivate cannabidiol medicinal cannabis. Verve Dynamics intends to cultivate and produce medicinal cannabis products and sell these product in South Africa. However, lack of formulation of a comprehensive law pertaining to medical marijuana in some states inhibits patient access to the drug.

 

Increase in the legalization of medicinal cannabis in various economies is expected to augment the market growth

 

Increasing approvals for medicinal cannabis products and growing research and development activities in the medicinal cannabis market are expected to support growth of the market. For instance, in March 2017, Germany’s parliament passed a law allowing medicinal use of the cannabis plant by allowing healthcare professionals to prescribe medicinal cannabis products to patients suffering from health issues such as chronic pain, vomiting, and nausea. However, health issues resulting from excessive cannabis consumption such as tachycardia, risk of heart attack, particularly in individuals with existing heart disease or arrhythmias, are expected to restrain growth of the market.

 

Legalization of medicinal cannabis is expected to grow once conclusive evidence regarding its safety and efficacy is obtained through extensive research. For instance, in 2013, Czech Republic legalized medicinal marijuana for patients suffering from chronic pain, epilepsy, chemotherapy induced side effects, and other severe disease indications. Furthermore, the law allows patients with marijuana prescription to purchase medicinal marijuana from pharmacies. However, cultivation of marijuana in not allowed in the country, and thereby suppliers need to import medicinal cannabis. These factors are expected to contribute to the growth of the medicinal cannabis use in pharmaceutical and biotechnology industry.

 

Medicinal Cannabis Market - Regional Insights

 

On the basis of region, the global medicinal cannabis market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

 

North America is expected to hold dominant position in the global medicinal cannabis market during the forecast period manufacturers U.S. medical cannabis market are focusing on expansion strategies to increase their product portfolio. For instance, in July 2016, Insys Therapeutics, Inc. received the U.S. Food and Drug Administration (FDA) approval for dronabinol oral solution, Syndros, an orally administered liquid formulation of the pharmaceutical, cannabinoid dronabinol. Syndros is indicated in treatment of anorexia associated with weight loss among patients suffering from AIDS and those suffering from cancer chemotherapy-induced nausea and vomiting.

 

Potential medicinal cannabis markets other than the U.S. include Canada, Israel, Australia, and Spain. Mexico is also in process of legalizing cannabis. For instance, in February 2016, Medical Marijuana, Inc. launched the HempMeds Mexico, a CBD hemp oil product, in Mexico. With the launch of HempMeds Mexico, the company intends to expand its cannabis business in Latin America by establishing labs, manufacturing facilities, and sales and distribution facilities in the region in the near future.

 

Moreover, companies operating in the North America market are adopting inorganic growth strategies, which is expected to drive growth of the market. For instance in, January 2018, Apria, Inc. entered into a distribution agreement with Cannabis Wheaton, to supply 60,000 kilograms of the cannabis products between January 2018 and February 2022. The agreement has allowed Apria to expand its brand through Cannabis Wheaton’s strong distribution network in Canada.

 

Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/40

 

Medicinal Cannabis Market - Competitive Landscape

 

Some of the key players operating in medicinal cannabis market include BOL Pharma, Tilray, Medreleaf Corporation, Aurora Cannabis, Inc., Canopy Growth Corporation, Insys Therapeutics, Inc., Aphria, Inc., MGC Pharmaceuticals Limited, GW Pharmaceuticals, plc., and Medical Marijuana Inc.

 

About Coherent Market Insights

 

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

 

 

Contact Us

 

Mr. Shah

Coherent Market Insights

1001 4th Ave, #3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Artificial Bone Market Competitive Analysis by Top Key Players with its Application, Product Types and Segmentation

Repairing of damaged bones is a critical clinical issue faced by orthopaedic surgeons, which is generally overcome by bone transplantation.

Nasal Drug Delivery Systems Market Competitive Landscape Report 2026: Pipeline, Epidemiology

Nasal cavity is becoming one of the most potential and promising route of drug delivery, owing to its advantages such as bypassing the hepatic first-pass metabolism, and most importantly patient convenience.

Metabolism Drugs Market Review, Descriptions, Analysis And Synthesis 2018

Increasing prevalence of pompe disease is expected to create lucrative opportunities for pharmaceutical manufacturers to develop and commercialize novel treatments for the disease.

Axillary Crutches Market Expansion to be Persistent During 2018 – 2026

Axillary crutches are the mobility aids used by individuals suffering from walking disability, factures, paralysis, and leg injuries.

Cancer Supportive Care Drugs Market Predicted to Grow at a Moderate Pace Through 2026

Cancer supportive care is associated with care given to the patients suffering from various types of cancer.

Antithrombin Appears To Improve In Time by 2026

Antithrombin is a protein present in blood that inhibits blood clotting by inactivating thrombin.

Theranostics 2018: Record Overwhelming Hike in Revenues by 2026

Theranostics involves combination of targeted diagnostic tests with targeted therapy.

New Developments with Operational Updates in Tissue Engineering Market

Tissue engineering is an interdisciplinary field addressed to develop functional three-dimensional tissues combining cells, scaffolds, and bioactive molecules.

Narcotics Analgesics Appears To Improve In Time by 2026

Narcotics analgesics also identified as opioids are the medications that imitate the activity of endorphins, elements produced by the body to regulate pain.

Tacrolimus 2018: Record Overwhelming Hike in Revenues by 2026

Tacrolimus is used as an immunosuppressant mainly after organ transplant procedures to prevent organ rejection.

Adipose Derived Stem Cell Therapy Market Upcoming Trends, Demand and Analysis Till 2026

Adipose derived stem cells (ADSCs) are stem cells derived from adipocytes, and can differentiate into variety of cell types.

Irrigation Syringe Market Enhancement and Growth Rate Analysis 2018-2026 Forecast by Global Top Players

Irrigation syringe is an instrument used to introduce medicated fluid into the body.